Allergan Presents Data at the ARVO Annual Meeting in Honolulu
04/26/2018
Allergan announced that 19 posters on their eye care offerings will be presented at this year’s ARVO meeting in Hawaii. These presentations will cover a variety of topics in various subspecialties, including ocular surface, glaucoma, and retina.
Retina Poster Presentations (Sunday, April 29th, 8:15AM-10:00AM)
- Pegylation of Abicipar Increases Vitreal Half-Life, Supporting a Potential for up to 3-Month Duration of Action in the Clinic
- Authors: Seal JR, et al.
- In Vitro and In Vivo Characterization of Abicipar Pegol, an anti-VEGF DARPin® Therapeutic
- Authors: Rodrigues GA, et al.
- Simulation of Ocular Drug Distribution Following Zero Order Release of Intravitreally Dosed Bevacizumab Using 3D Computational Fluid Dynamic Model
- Authors: Shen J, et al.
Glaucoma Poster Presentations
- A Rabbit Model for Glaucoma Filtration Surgery
- Authors: Nagar S, et al., Sunday, April 29th, 1:00PM-2:45PM
- Patient-reported Outcomes of Bimatoprost Ocular Ring in an Open-label Extension Study in Patients with Open-angle Glaucoma or Ocular Hypertension
- Authors: Chen M, et al., Monday, April 30th, 8:15AM-10:00AM
- Intravitreal Brimonidine Drug Delivery System (Brimo DDS Generation 1) Enhances Spatial Sweep Visual Evoked Potential (sVEP) in a Nonhuman Primate Model of Chronic Glaucoma
- Authors: Burke J, et al., Monday, April 30th, 8:15AM-10:00AM
- In Vivo Angiographic Study of Rabbit Aqueous Outflow following Ab Interno Gelatin Stent Implantation
- Authors: Lee SS, et al., Monday, April 30th, 11:15AM-1:00PM
- Visualization of Conjunctival Lymphatic Vessels in Normotensive Rabbits
- Authors: Rajagopalan L, et al., Monday, April 30th, 11:15AM-1:00PM
- A Novel Iridocorneal Angle Measurement Technique: Assessment of Inter-and Intra-Scorer Variability
- Authors: Nguyen A, et al., Monday, April 30th, 11:15AM-1:00PM
- Complete Responders Following Ab Interno Gelatin Stent at 12M in Refractory Glaucoma Patients
- Authors: Robinson MR, et al., Monday, April 30th, 3:30PM-5:15PM
- Treatment Experience of Open Angle Glaucoma Patients Undergoing Trabeculectomy in the US
- Authors: Patel A, et al., Wednesday, May 2nd, 3:30PM-5:15PM
- Using a Novel Anterior Segment Optical Coherence Tomography (AS-OCT) Method to Assess Iridocorneal Angle
- Authors: Goldberg J, et al., Thursday, May 3rd, 8:15AM-10:00AM
- fMRI shows Functional Recovery by Intravitreal Brimonidine Drug Delivery System (Brimo DDS Generation 1) in a Rabbit Model of Retinal Ganglion Cell (RGC) Degeneration
- Authors: Ghosn C, et al., Thursday, May 3rd, 11:00AM-12:45PM
Ocular Surface Treatment Poster Presentations
- Effect of TrueTear on Dry Eye Symptoms During Exposure to a Controlled Adverse Environment
- Authors: Senchyna M, et al., Sunday, April 29th, 3:15PM-5:00PM
- The Repeatability of Tear Film Measurements in Subjects with Dry Eye
- Authors: Stapleton F, et al., Sunday, April 29th, 3:15PM-5:00PM
- Evaluation of the Durability of Dry Symptom Relief Following Daily Use of TrueTearTM
- Authors: Penzner J, et al., Sunday, April 29th, 3:15PM-5:00PM
- Changes in Tear Lipid Layer Thickness with Omega-3 Eye Drop
- Authors: Fogt J, et al., Tuesday, May 1st, 3:30PM-5:15PM
- Organic Osmolytes as Osmotic Agents vs. Salts in Artificial Tears
- Authors: Liu H, et al., Wednesday, May 2nd, 11:15AM-1:00PM
- Sodium Concentration Affects the Physical Properties of Hyaluronic Acid-based Lubricant Eye Drops
- Authors: Simmons PA, et al., Wednesday, May 2nd, 11:15AM-1:00PM